Related Experiment Video
Updated: Jun 22, 2026

07:22
A Standardized Procedure of Dressing Management for Toxic Epidermal Necrolysis
Published on: March 14, 2025
Severe irritant contact dermatitis causing skin ulceration secondary to a testosterone patch
Nathan Lawrentschuk1, Neil Fleshner
1Division of Urology, University of Toronto, Canada. nayjay@ozemail.com.au
Thescientificworldjournal
|May 27, 2009
Summary
Testosterone replacement therapy, particularly topical gels and patches, is increasingly used for men with low testosterone. This case highlights a rare side effect of ulceration from testosterone skin patches, emphasizing the need for careful management.
Area of Science:
- Endocrinology
- Dermatology
- Pharmacology
Background:
- Testosterone replacement therapy (TRT) has evolved with topical formulations like patches and gels.
- There is growing interest in treating age-related testosterone decline in men, termed andropause.
- TRT is increasingly personalized to individual patient needs.
Observation:
- Skin reactions are known side effects of testosterone patches, with irritant contact dermatitis being most common.
- Ulceration of the skin has not been previously reported as a side effect of testosterone transdermal therapies.
- This case presents a patient experiencing ulceration associated with testosterone patch use.
Findings:
- Testosterone transdermal therapies, while beneficial, carry potential risks.
- The case study details a rare adverse event (ulceration) linked to testosterone patches.
- Management strategies for such side effects are crucial for patient safety.
Implications:
- This finding expands the known spectrum of side effects for testosterone transdermal treatments.
- As topical testosterone therapies become more prevalent, awareness of potential complications like ulceration is essential.
- Further research into the mechanisms and prevention of these rare side effects is warranted.
Related Concept Videos
Drug Toxicity: Allergic Reactions
Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...
Skin Diseases and Disorders
Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Hypersensitivity Reactions: Immune-Complex Reactions
Type III hypersensitivity reactions occur when antigen–antibody complexes form and activate the complement system. Normally, these complexes help the clearance of antigens by phagocytes and red blood cells. However, when large numbers of immune complexes are present, they can deposit in tissues—particularly in the walls of blood vessels—leading to inflammation and tissue injury. These deposits trigger complement activation and neutrophil recruitment, resulting in serum sickness, a systemic...
Transdermal Drug Delivery Systems
Transdermal drug delivery systems (TDDS) enable the controlled release of drugs across the skin into systemic circulation. They are particularly advantageous for drugs with short half-lives or narrow therapeutic indices, as they maintain consistent plasma concentrations and reduce the risk of subtherapeutic or toxic levels.TDDS are categorized into monolithic, reservoir, and mixed systems. Monolithic systems embed the drug in a polymer matrix, where diffusion governs release. Reservoir systems...
Staphylococcal Skin Infections
Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Diabetic Foot Ulcer
Definition A diabetic foot ulcer (DFU) is a chronic, non-healing wound that develops in individuals with diabetes. It typically occurs on pressure-bearing areas such as the heel, metatarsal heads, or hallux, and carries a high risk of infection and amputation.Pathophysiology • The development of DFUs can be explained by four interconnected mechanisms: neuropathy, ischemia, infection, and impaired wound healing. • Neuropathy is the most common factor. Sensory neuropathy reduces pain perception,...